Skip to main content
. Author manuscript; available in PMC: 2009 Jul 3.
Published in final edited form as: Oncogene. 2008 Mar 10;27(29):4065–4074. doi: 10.1038/onc.2008.48

Figure 6. Proteasomal processing of EGFp21 fusion protein.

Figure 6

H1299-EGFp21 cells were treated for 24 hours with doxycycline (2µg/mL) to induce EGFp21 expression and then with cyclohexamide (50µg/mL) in the absence or presence of the proteasome inhibitor MG132 (50μM). Protein lysates were harvested at 1, 2, 3, 6 and 9 hours post treatment and immunoblotted for EGFp21 and actin. Blots are representative of 3–4 experiments.